Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00099"

Predicate	Value (sorted: default)
rdfs:label	"Filgrastim"
rdf:type	drugbank:drugs
drugbank:description	"Filgrastim is a recombinant, non-pegylated human granulocyte colony stimulating factor (G-CSF) analogue manufactured by recombinant DNA technology using a strain of E. coli. It is marketed as the brand name Neupogen by Amgen. Chemically, it consists of 175 amino acid residues. The protein has an amino acid sequence that is identical to the natural sequence predicted from human DNA sequence analysis, except for the addition of an N-terminal methionine necessary for expression in E coli. Tbo-filgrastim, which is marketed by Sicor Biotech and FDA approved on August 29, 2012, contains the same active ingredient as Neupogen and is biologically similar, but it is formulated to be short-acting."
drugbank:drugCategory	drugcategory:Antineutropenic Agents drugcategory:Hematopoietic Agents drugcategory:Immunosuppressive Agents
drugbank:interactsWith	drug:Topotecan
owl:sameAs	drug:BIOD00072 drug:BTD00072 drug:Topotecan

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines2/drugbank_small.nt

The resource appears as object in 2 triples

Context graph